Boston Scientific Corporation (0HOY.L)
USD 94.72
(1.06%)
USD 94.72
(1.06%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 9.84 Billion USD | 27.68% |
| 2022 | 7.71 Billion USD | 3.39% |
| 2021 | 7.46 Billion USD | 33.81% |
| 2020 | 5.57 Billion USD | -18.94% |
| 2019 | 6.87 Billion USD | 6.21% |
| 2018 | 6.47 Billion USD | 10.32% |
| 2017 | 5.87 Billion USD | 9.88% |
| 2016 | 5.34 Billion USD | 0.79% |
| 2015 | 5.3 Billion USD | 4.1% |
| 2014 | 5.09 Billion USD | 5.45% |
| 2013 | 4.82 Billion USD | 1.56% |
| 2012 | 4.75 Billion USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.38 Billion USD | 3.11% |
| 2024 Q2 | 2.84 Billion USD | 19.17% |
| 2024 Q3 | 2.89 Billion USD | -6.79% |
| 2023 Q3 | 2.16 Billion USD | -4.79% |
| 2023 Q4 | 2.31 Billion USD | 6.69% |
| 2023 Q1 | 2.07 Billion USD | 6.24% |
| 2023 Q2 | 2.27 Billion USD | 9.58% |
| 2023 FY | 8.83 Billion USD | 14.48% |
| 2022 Q4 | 1.95 Billion USD | 1.4% |
| 2022 Q2 | 1.98 Billion USD | 7.87% |
| 2022 Q1 | 1.84 Billion USD | -5.05% |
| 2022 FY | 7.71 Billion USD | 3.39% |
| 2022 Q3 | 1.92 Billion USD | -3.02% |
| 2021 Q3 | 1.83 Billion USD | -5.66% |
| 2021 FY | 7.46 Billion USD | 33.81% |
| 2021 Q1 | 1.84 Billion USD | -11.51% |
| 2021 Q2 | 1.94 Billion USD | 5.2% |
| 2021 Q4 | 1.94 Billion USD | 5.95% |
| 2020 Q3 | 1.77 Billion USD | 47.67% |
| 2020 Q4 | 2.08 Billion USD | 17.32% |
| 2020 FY | 5.57 Billion USD | -18.94% |
| 2020 Q1 | 1.72 Billion USD | -18.4% |
| 2020 Q2 | 1.2 Billion USD | -30.2% |
| 2019 Q3 | 1.91 Billion USD | 3.18% |
| 2019 Q2 | 1.85 Billion USD | 6.24% |
| 2019 FY | 6.87 Billion USD | 6.21% |
| 2019 Q1 | 1.74 Billion USD | -6.43% |
| 2019 Q4 | 2.11 Billion USD | 10.39% |
| 2018 Q3 | 1.7 Billion USD | -1.73% |
| 2018 Q1 | 1.68 Billion USD | -2.71% |
| 2018 Q2 | 1.73 Billion USD | 2.66% |
| 2018 Q4 | 1.86 Billion USD | 9.57% |
| 2018 FY | 6.47 Billion USD | 10.32% |
| 2017 Q1 | 1.5 Billion USD | -5.23% |
| 2017 FY | 5.87 Billion USD | 9.88% |
| 2017 Q4 | 1.73 Billion USD | 9.87% |
| 2017 Q3 | 1.58 Billion USD | -2.47% |
| 2017 Q2 | 1.62 Billion USD | 7.64% |
| 2016 FY | 5.34 Billion USD | 0.79% |
| 2016 Q1 | 1.37 Billion USD | -4.04% |
| 2016 Q2 | 1.47 Billion USD | 7.04% |
| 2016 Q3 | 1.49 Billion USD | 1.7% |
| 2016 Q4 | 1.58 Billion USD | 5.94% |
| 2015 Q4 | 1.43 Billion USD | 7.33% |
| 2015 Q3 | 1.33 Billion USD | 3.4% |
| 2015 FY | 5.3 Billion USD | 4.1% |
| 2015 Q2 | 1.29 Billion USD | 4.36% |
| 2015 Q1 | 1.23 Billion USD | -6.21% |
| 2014 FY | 5.09 Billion USD | 5.45% |
| 2014 Q2 | 1.28 Billion USD | 7.42% |
| 2014 Q4 | 1.32 Billion USD | 2.88% |
| 2014 Q3 | 1.28 Billion USD | -0.39% |
| 2014 Q1 | 1.2 Billion USD | -4.53% |
| 2013 Q1 | 1.14 Billion USD | -5.78% |
| 2013 Q3 | 1.19 Billion USD | -2.84% |
| 2013 Q4 | 1.25 Billion USD | 5.01% |
| 2013 FY | 4.82 Billion USD | 1.56% |
| 2013 Q2 | 1.23 Billion USD | 7.88% |
| 2012 Q4 | 1.21 Billion USD | 0.0% |
| 2012 FY | 4.75 Billion USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Phreesia, Inc. | 201.74 Million USD | -4781.905% |
| Accuray Incorporated | 143.12 Million USD | -6781.59% |
| Align Technology, Inc. | 2.72 Billion USD | -262.074% |
| Elevance Health Inc. | 47.01 Billion USD | 79.049% |
| AxoGen, Inc. | 127.87 Million USD | -7602.113% |
| CVS Health Corporation | 54.43 Billion USD | 81.906% |
| Cardinal Health, Inc. | 7.41 Billion USD | -32.843% |
| Centene Corporation | 153.99 Billion USD | 93.605% |
| DaVita Inc. | 3.82 Billion USD | -157.798% |
| HCA Healthcare, Inc. | 55.06 Billion USD | 82.114% |
| Hologic, Inc. | 2.23 Billion USD | -340.12% |
| Humana Inc. | 106.44 Billion USD | 90.747% |
| IDEXX Laboratories, Inc. | 2.18 Billion USD | -349.732% |
| Laboratory Corporation of America Holdings | 3.36 Billion USD | -192.698% |
| Masimo Corporation | 1 Billion USD | -881.465% |
| McKesson Corporation | 12.58 Billion USD | 21.734% |
| Patterson Companies, Inc. | 1.38 Billion USD | -613.571% |
| Quest Diagnostics Incorporated | 2.96 Billion USD | -232.624% |
| ResMed Inc. | 2.6 Billion USD | -277.533% |
| Henry Schein, Inc. | 3.65 Billion USD | -169.762% |
| Teladoc Health, Inc. | 1.84 Billion USD | -434.579% |
| Universal Health Services, Inc. | 1.17 Billion USD | -737.941% |
| Veeva Systems Inc. | 1.68 Billion USD | -484.031% |
| Baxter International Inc. | 4.97 Billion USD | -97.97% |
| Becton, Dickinson and Company | 8.82 Billion USD | -11.629% |
| Intuitive Surgical, Inc. | 4.72 Billion USD | -108.246% |
| Danaher Corporation | 14.12 Billion USD | 30.292% |
| Stryker Corporation | 13.05 Billion USD | 24.575% |
| Medtronic plc | 21.27 Billion USD | 53.702% |